Masa-aki A. Kawashiri

Efficacy and Safety of Evinacumab in Japanese Patients with Homozygous Familial Hypercholesterolemia: Long-term Results from an Open-label, Single-arm, Phase 3 Trial.

Journal: Journal of atherosclerosis and thrombosis

Published: July 01, 2026

Impact of Genetic Testing Among Patients With Familial Hypercholesterolemia on Adverse Cardiovascular Events　- The Hokuriku-Plus Familial Hypercholesterolemia Registry Study.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: March 22, 2026

Beyond Familial Hypercholesterolemia: Your Feet can Help Predict Your Coronary Atherosclerosis.

Journal: Journal of atherosclerosis and thrombosis

Published: March 08, 2026

Energy spectrum-based correction of washout rates in dual-isotope 123I-BMIPP/201Tl imaging.

Journal: Annals of nuclear medicine

Published: February 26, 2026

A Catalog of the Pathogenic Variants in ABCG5 and ABCG8 and Clinical Features in Sitosterolemia.

Journal: Journal of atherosclerosis and thrombosis

Published: February 11, 2026

Significance of Clinical and Genetic Signatures of Familial Hypercholesterolemia Among Patients With Severe Hypercholesterolemia.

Journal: JACC. Advances

Published: June 20, 2025

Sex Differences in the Diagnosis and Treatment of Japanese Patients With Familial Hypercholesterolemia: A Retrospective Cohort Study.

Journal: Journal of lipid and atherosclerosis

Published: April 27, 2025

Impact of Achilles tendon on diagnosis and phenotypes of familial hypercholesterolemia.

Journal: Current opinion in lipidology

Published: April 25, 2025

Protein-truncating variants of the cholesteryl ester transfer protein gene and risk for coronary artery disease among patients with heterozygous familial hypercholesterolemia.

Journal: Atherosclerosis

Published: April 12, 2025

Impact of Genetic Testing and Sex Differences among Patients with Familial Hypercholesterolemia: The Hokuriku-plus Familial Hypercholesterolemia Registry Study.

Journal: Journal of atherosclerosis and thrombosis

Published: January 05, 2025

Triple Assessments of Atherosclerosis in Patients With Heterozygous Familial Hypercholesterolemia.

Journal: JACC. Asia

Published: December 20, 2024

Impact of the clinical diagnostic strata of familial hypercholesterolemia on risk stratification among patients with hypercholesterolemia.

Journal: Atherosclerosis

Published: December 15, 2024

Efficacy and Safety of Evinacumab in Japanese Patients with Homozygous Familial Hypercholesterolemia: Long-term Results from an Open-label, Single-arm, Phase 3 Trial.

Efficacy and Safety of Evinacumab in Japanese Patients with Homozygous Familial Hypercholesterolemia: Long-term Results from an Open-label, Single-arm, Phase 3 Trial.

Impact of Genetic Testing Among Patients With Familial Hypercholesterolemia on Adverse Cardiovascular Events - The Hokuriku-Plus Familial Hypercholesterolemia Registry Study.

Impact of Genetic Testing Among Patients With Familial Hypercholesterolemia on Adverse Cardiovascular Events - The Hokuriku-Plus Familial Hypercholesterolemia Registry Study.

Beyond Familial Hypercholesterolemia: Your Feet can Help Predict Your Coronary Atherosclerosis.

Beyond Familial Hypercholesterolemia: Your Feet can Help Predict Your Coronary Atherosclerosis.

Energy spectrum-based correction of washout rates in dual-isotope 123I-BMIPP/201Tl imaging.

Energy spectrum-based correction of washout rates in dual-isotope 123I-BMIPP/201Tl imaging.

A Catalog of the Pathogenic Variants in ABCG5 and ABCG8 and Clinical Features in Sitosterolemia.

A Catalog of the Pathogenic Variants in ABCG5 and ABCG8 and Clinical Features in Sitosterolemia.

Significance of Clinical and Genetic Signatures of Familial Hypercholesterolemia Among Patients With Severe Hypercholesterolemia.

Significance of Clinical and Genetic Signatures of Familial Hypercholesterolemia Among Patients With Severe Hypercholesterolemia.

Sex Differences in the Diagnosis and Treatment of Japanese Patients With Familial Hypercholesterolemia: A Retrospective Cohort Study.

Sex Differences in the Diagnosis and Treatment of Japanese Patients With Familial Hypercholesterolemia: A Retrospective Cohort Study.

Impact of Achilles tendon on diagnosis and phenotypes of familial hypercholesterolemia.

Impact of Achilles tendon on diagnosis and phenotypes of familial hypercholesterolemia.

Protein-truncating variants of the cholesteryl ester transfer protein gene and risk for coronary artery disease among patients with heterozygous familial hypercholesterolemia.

Protein-truncating variants of the cholesteryl ester transfer protein gene and risk for coronary artery disease among patients with heterozygous familial hypercholesterolemia.

Impact of Genetic Testing and Sex Differences among Patients with Familial Hypercholesterolemia: The Hokuriku-plus Familial Hypercholesterolemia Registry Study.

Impact of Genetic Testing and Sex Differences among Patients with Familial Hypercholesterolemia: The Hokuriku-plus Familial Hypercholesterolemia Registry Study.

Triple Assessments of Atherosclerosis in Patients With Heterozygous Familial Hypercholesterolemia.

Triple Assessments of Atherosclerosis in Patients With Heterozygous Familial Hypercholesterolemia.

Impact of the clinical diagnostic strata of familial hypercholesterolemia on risk stratification among patients with hypercholesterolemia.

Impact of the clinical diagnostic strata of familial hypercholesterolemia on risk stratification among patients with hypercholesterolemia.

Impact of Genetic Testing Among Patients With Familial Hypercholesterolemia on Adverse Cardiovascular Events　- The Hokuriku-Plus Familial Hypercholesterolemia Registry Study.

Impact of Genetic Testing Among Patients With Familial Hypercholesterolemia on Adverse Cardiovascular Events　- The Hokuriku-Plus Familial Hypercholesterolemia Registry Study.